Abstract #1031

Substituting Gadolinium In Human Brain MRI Using DeepContrast

Chen Liu^1,2, Nanyan Zhu^1,3, Xinyang Feng^4,5, Frank A Provenzano⁶, John T Vaughan^4,7,8, Scott A Small^6,7,9, and Jia Guo^8,9

¹These authors contribute equally to this work and are joint first authors, New York, NY, United States, ²Electrical Engineering, Columbia University, New York, NY, United States, ³Biological Science, Columbia University, New York, NY, United States, ⁴Biomedical Engineering, Columbia University, New York, NY, United States, ⁵Facebook, San Francisco, NY, United States, ⁶Neurology, Columbia University, New York, NY, United States, ⁷Radiology, Columbia University, New York, NY, United States, ⁸Mortimer B. Zuckerman Mind Brain Behavior Institute, Columbia University, New York, NY, United States, ⁹Psychiatry, Columbia University, New York, NY, United States

MRI estimation of cerebral blood volume (CBV) is useful in mapping potential brain function. To obtain high-resolution CBV maps, it typically requires intravenous (IV) injections of Gadolinium-based contrast agents (GBCAs), the use of which has come under new scrutiny. Here, we design and implement a deep learning algorithm, DeepContrast, to estimate GBCA contrast directly from T1-weighted (T1W) structural MRI. The predicted contrast performs equally well as the GBCA-enhanced CBV map even in mapping subtle age-related functional changes in the human brain. Therefore, our study demonstrates the feasibility of substituting GBCA in human brain MRI using DeepContrast.

This abstract and the presentation materials are available to members only; a login is required.

Join Here